Effects of COVID-19 on the liver: The experience of a single center

Table 8 Data from patients with acute liver failure

Gender	Age	Outcome	COVID severity	Respiratory failure, SpO2, respiratory rate	O2	Laboratory tests	COVID complications	Comorbidities
Male	84	Deceased	Critical	Yes, 83%, 18/min	No	ALT 107, ALP 117, GGT 107, LDH 743, Alb 29.3	Sepsis; Electrolytes imbalance; Hypokalemia; Acid-alkaline imbalance	Heart disease; Epilepsy
Male	55	Deceased	Critical	Yes, 91%, 34/min	Yes	CRP 111, IL-6 87, ALT 115, AST 344, ALP 40, LDH 448, Alb 28.1	Sepsis; Hypokalemia; Hyponatremia; Blood coagulation disorder	Primary hypertension; Obesity; Antibiotic resistance
Male	44	Recovered	Moderate	No, 94%, 16/min	No	CRP 98, IL-6 54, ALT 113, AST 193, ALP 73, GGT 355, LDH 399	Hypokalemia	Primary hypertension; Heart disease; Kidney disease
Male	42	Deceased	Critical	Yes, 80%, 30/min	Yes	CRP 459, IL-6 99, ALT 162, AST 183, ALP 1183, GGT 67, LDH 900, Alb 16.6	Acute kidney failure; Sepsis; Bacterial pneumonia complication; Hypokalemia; Blood coagulation disorder	Urinary tract infection; Anemia; Antibiotic resistance
Male	50	Deceased	Moderate	No, 98%, 22/min	No	CRP 221, IL-6 626, ALT 521, AST 53, ALP 296, GGT 559, LDH 546, Alb 16.5	Acute kidney failure; Sepsis; Blood coagulation disorder; Hypokalemia	Heart disease; Cancer (lymphoma)

COVID: Coronavirus disease; CRP: C-reactive protein; LDH: Lactate dehydrogenase; IL-6: Interleukine-6; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; ALP: Alkaline phosphatase; Alb: Albumin.